Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Nestin is found in hair follicle progenitor cells, linking them to neural stem cells.

Nestin-expressing hair follicle cells may be useful for nerve repair and regeneration.

New hair follicles could be created to treat hair loss.

QR678 Neo is more effective than PRP for hair growth and quality.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Breast cancer alters specific molecular structures in hair, which revert after cancer removal.

Early puberty is more common in girls and African-American children, possibly due to nutrition, obesity, stress, and environmental factors, and is treated with hormone therapy.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

PHGDH promotes cancer growth by aiding cell proliferation and tumor progression.

Hedgehog signaling controls hair follicle development and can affect skin cancer growth.

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

Nestin marks cells that can become a specific type of skin cell in hair follicles of both developing and adult mice.

The study found that aging hair follicle stem cells change behavior, leading to hair loss, but drugs targeting these cells may help restore hair growth.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

The experiment showed that human skin grown in the lab started to form early hair structures when special cell clusters were added.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Basal cell epithelioma resembles fetal hair follicles, not adult or fetal skin.

Early hair loss may indicate future prostate issues.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Removing p16INK4a from skin cells can lead to faster and more clumped growth, which might help with hair growth.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Including androgens in hormone therapy may lower breast cancer risk.

More research is needed to understand chemotherapy-induced hair loss and its phases.